220260 — Chemtros Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩153bn
- KR₩170bn
- KR₩47bn
- 61
- 25
- 12
- 20
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,032 | 8,305 | 26,791 | 26,440 | 11,550 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 8,266 | 8,187 | 9,344 | 10,885 | 7,965 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 21,134 | 23,812 | 48,475 | 50,705 | 34,941 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 42,297 | 45,386 | 45,337 | 44,974 | 58,926 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 68,066 | 71,479 | 95,237 | 97,459 | 97,845 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 16,637 | 14,604 | 15,881 | 16,360 | 30,951 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 23,523 | 25,428 | 40,263 | 38,509 | 36,162 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 44,543 | 46,050 | 54,974 | 58,950 | 61,683 |
Total Liabilities & Shareholders' Equity | 68,066 | 71,479 | 95,237 | 97,459 | 97,845 |
Total Common Shares Outstanding |